Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Skin spheroids with both outer and inner layers are key for regrowing skin patterns and hair.

Biomimetic scaffolds are better than traditional methods for growing cells and could help regenerate various tissues.

The document explains the difficulty in diagnosing and treating brain diseases caused by the immune system and stresses the need for quick and accurate tests.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Erdr1 could be a new marker for diagnosing hair loss.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Premature graying and hair changes can be treated with certain peptides and possibly targeting the endocannabinoid system.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

Thyroid disease can cause skin, hair, and nail problems, and treating the thyroid condition often improves these symptoms.

New treatments for hair growth disorders are needed due to limited current options and complex hair follicle biology.

New therapies show promise for wound healing, but more research is needed for safe, affordable options.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Early and personalized treatment for hair loss in young people is crucial to prevent permanent damage and should include psychological support.

Gonadal hormones significantly affect the severity of alopecia areata in mice.

The document concludes that identifying the cause of eyebrow and eyelash loss is key to treating it and improving quality of life.

PRP helps with skin, hair, and wound treatments but needs more research for standard use.

Various skin conditions can be treated effectively with different methods, such as discontinuing certain drugs, using specific vaccines, applying creams, and changing lifestyle habits like smoking and drinking.

Cepharanthine has many medicinal uses but needs improvement for better effectiveness.

Melatonin is important for skin health and protection, and can be made by the skin or applied to it.

Nanocarriers can improve antioxidant delivery to the skin but face safety and production challenges.

Chitosan, a natural substance, can be used to create tiny particles that effectively deliver various types of drugs, but more work is needed to improve stability and control of drug release.

New treatments for hair loss are promising.

SIRT3 and SIRT7 genes may play a role in hair loss.

Recognizing scalp symptoms in PRP is crucial for proper diagnosis and treatment.

T-regulatory cells are important for skin health and can affect hair growth and reduce skin inflammation.

Plant-based chemicals may help hair growth and prevent hair loss but need more research to compete with current treatments.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.